| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_LPAR1_0004100 | Intron-Exon-Intron | chr9:113734353-113767819 | chr9:110972073-111005539 | 250 nt | 0.4360 |
| hsa_LPAR1_0004200 | Intron-Exon-Intron | chr9:113734353-113771481 | chr9:110972073-111009201 | 250 nt | 0.3120 |
| hsa_LPAR1_0004300 | Intron-Exon-Intron | chr9:113734353-113773970 | chr9:110972073-111011690 | 250 nt | 0.3560 |
| hsa_LPAR1_0004400 | Intron-Exon-Intron | chr9:113734353-113798481 | chr9:110972073-111036201 | 250 nt | 0.4160 |
| hsa_LPAR1_0005200 | Exon-Exon | chr9:113734353-113800365 | chr9:110972073-111038085 | 471 nt | 0.6391 |
| hsa_LPAR1_0005400 | Exon-Exon | chr9:113735761-113735838 | chr9:110973481-110973558 | 78 nt | 0.5000 |
| hsa_LPAR1_0005500 | Intron-Exon-Intron | chr9:113735761-113773970 | chr9:110973481-111011690 | 250 nt | 0.3360 |
| hsa_LPAR1_0005800 | Intron-Intron | chr9:113767745-113773970 | chr9:111005465-111011690 | 250 nt | 0.3360 |
| hsa_LPAR1_0006100 | Intron-Intron | chr9:113771428-113773970 | chr9:111009148-111011690 | 2543 nt | 0.3236 |
| hsa_LPAR1_0007000 | Intron-Intron | chr9:113773828-113773970 | chr9:111011548-111011690 | 143 nt | 0.3776 |
A study in humans demonstrated that the circLPAR1 is expressed at low levels in muscle-invasive bladder cancer (MIBC) tissues, where its low expression predicts worse disease-specific survival and is associated with invasion and metastasis [Di Agostino et al. DOI:10.3389/fcell.2020.00389].